If you wish to download the documents, please click on the links below:
Current EAMBES Governance and the past Executives of EAMBES.
The Innovative Medicines Imitative 2 (IMI) has announced that it will hold a total of three webinars from the 11-15 July 2014 so as to better acquaint those wishing to apply for the IMI 2–Call 1 for proposals with the application process and the subject matters of the recently announce initial calls . This information was published in the IMI newsletter on the 30 June.
The IMI is a public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) and will replace and succeed IMI Joint Undertaking (JU).
The webinars offered ample opportunity for all attendees to interact directly with the topic coordinators, and get in touch with potential project partners, particularly given that webinars on the call topics featured a presentation by the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) topic coordinator, as well as a question and answer segment. Additionally, the webinar on IMI2’s new rules and procedures including presentations of IMI2's intellectual property policy and tips on the preparation of an Expression of Interest (EoI).
The most relevant webinar for EAMBES was entitled: “new procedures, rules, guidance & IPR for Calls for proposals” and the presentations from the webinar can be accessed here. The call documents and deadlines for IMI2 along with the indicative timetable for evaluation and grant agreement can be accessed here.